Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery

OBJECTIVE: Stereotactic radiosurgery (SRS) is routinely used to treat brain metastases from melanoma due to their radioresistant nature. The median survival for these patients is 4–6 months, according to earlier studies. The aim of this study was to evaluate prognostic factors that influence surviva...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Neurosurg
Hlavní autoři: Bian, Shelly X., Routman, David, Liu, Jonathan, Yang, Dongyun, Groshen, Susan, Zada, Gabriel, Trakul, Nicholas, Wong, Michael K., Yu, Cheng, Chang, Eric L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7469983/
https://ncbi.nlm.nih.gov/pubmed/27903181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3171/2016.8.GKS161359
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky